معرفی
David G Bermudes is a Professor in the Department of Biology within the College of Science and Mathematics at California State University, Northridge (CSUN). His research focuses on developing tumor-targeting bacterial therapies for cancer treatment, with particular emphasis on genetically modified Salmonella strains.
His educational background includes a Ph.D. from Boston University (1987) and a B.A. from Oberlin College (1982). His laboratory employs biochemical, cell and molecular biological techniques to engineer bacteria with enhanced tumor-targeting capabilities and anticancer efficacy.
Research interests center on therapeutic bacteria for cancer therapy, with specific focus on:
- Genetic modification of pathogenic bacteria to target solid tumors
- Development of chimeric protein toxins for bacterial expression
- Overcoming cancer therapy resistance mechanisms
- Protease inhibitor systems to protect therapeutic proteins
- Tryptophan metabolism modulation in tumor microenvironments
His publication trends demonstrate consistent innovation in bacterial vector engineering, with recent work (2020-2025) emphasizing protease inhibition systems, tumor-penetrating chimeric peptides, and applications extending to vaccine development (including SARS-CoV-2 research). The research spans molecular engineering, tumor biology, and translational therapeutic development.
Professor Bermudes teaches Medical Microbiology (BIOL 410) and supervises independent research (BIOL 699A). His laboratory provides students with training in DNA manipulation, transposon library generation, chromosomal engineering, gene cloning, bioinformatics, and mammalian tissue culture techniques. His work has established foundational approaches for using attenuated bacteria as tumor-targeted delivery vectors for therapeutic proteins and prodrug-converting enzymes.
